SCHEMBL297823

SCHEMBL297823

CC(C)(C)c1cc(C2(c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)CCCCC2)cc(C(C)(C)C)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.58
CA2 P00918 4/20 0.48
CA1 P00915 2/20 0.48
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
POLB P06746 1/20 0.47
TYR P14679 1/20 0.47
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
ESR1 P03372 4/20 0.44
ESR2 Q92731 4/20 0.44
MAPT P10636 2/20 0.42
ALOX15 P16050 2/20 0.42
HPN P05981 1/20 0.42
SIRT5 Q9NXA8 1/20 0.42
CYP1A2 P05177 2/20 0.41
ATP2A2 P16615 1/20 0.41
ATP2A3 Q93084 1/20 0.41
HTT P42858 2/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17532650 0.94 CA2 (0.50) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL9807748 0.90 ACHE (0.71) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL31287210 0.88 ACHE (0.50) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL297680 0.88 ACHE (0.50) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL30443121 0.88 ACHE (0.50) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL298887 0.88 ACHE (0.50) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL17532649 0.87 ACHE (0.68) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL18802808 0.87 ACHE (0.56) ACHECA2CA1ALDH1A1SMN1; SMN2
SCHEMBL5573143 0.81 CA2 (0.45) CA2CA1ALDH1A1SMN1; SMN2POLB
SCHEMBL296363 0.80 ESR1 (0.62) ACHEALDH1A1SMN1; SMN2TYRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763560-A1 POLYARYLATE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 2007-03-21 EP claimed
US-7109274-B2 Polyarylate compositions GENERAL ELECTRIC COMPANY (US) 2006-09-19 US claimed
WO-2006012161-A1 POLYARYLATE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 2006-02-02 WO claimed
US-20060004152-A1 Polyarylate compositions GENERAL ELECTRIC COMPANY 2006-01-05 US claimed
EP-1560871-A1 METHOD FOR MAKING COPOLYCARBONATES GENERAL ELECTRIC COMPANY (US) 2005-08-10 EP claimed
WO-2004041907-A1 METHOD FOR MAKING COPOLYCARBONATES GENERAL ELECTRIC COMPANY (US) 2004-05-21 WO claimed
US-6657038-B1 Melt condensation copolymerization of dihydroxyaromatic compounds and diphenyl carbonate derivative in presence of metal hydroxide and quaternary phosphonium salt GENERAL ELECTRIC COMPANY 2003-12-02 US claimed
US-6576739-B2 Conversion of the hindered bisphenol to the corresponding bischloroformate and subsequent treatment with an amine catalyst and an aqueous base to effect polymerization by hydrolysis and condenstation of bischloroformate groups GENERAL ELECTRIC COMPANY 2003-06-10 US claimed
US-20020111456-A1 Method of polycarbonate preparation SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2002-08-15 US claimed
WO-2001085825-A2 METHOD OF POLYCARBONATE PREPARATION GENERAL ELECTRIC COMPANY (US) 2001-11-15 WO claimed
US-4769178-A Cold-rolling lube oil for metallic materials KAO CORPORATION (JP) 1988-09-06 US claimed
US-4746448-A ESTER, DIMER OR POLYMERIZED ACID, POLYESTER OR FATTY OIL, NITROGEN POLYMER KAO CORPORATION (JP) 1988-05-24 US claimed
EP-4715960-A1 METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT Dr. Ing. h.c. F. Porsche Aktiengesellschaft (DE) 2026-03-25 EP disclosed
EP-4715023-A1 HEAT TRANSFER FLUID ExxonMobil Technology and Engineering Company (US) 2026-03-25 EP disclosed
US-20260081259-A1 METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT ExxonMobil Technology and Engineering Company (US) 2026-03-19 US disclosed
US-12358399-B2 Monitoring health of heat transfer fluids for electric systems ExxonMobil Technology and Engineering Company (US) 2025-07-15 US disclosed
US-4271059-A Color-developing composition for pressure-sensitive recording sheet material and process for the preparation thereof containing phenolic resin and hindered phenol MITSUI TOATSU CHEMICALS INC. (JP) 1981-06-02 US disclosed
US-4235769-A COPOLYMER OF P-ALKYLPHENOL, PHENOL AND FORMALDEHYDE, 6-(4-HYDROXY-3,5-DI-TERTBUTYLANILINO)-2,4-BIS(ALKYLTHIO)-S-TRIAZINES MITSUI TOATSU CHEMICALS, INC. (JP) 1980-11-25 US disclosed
US-4013618-A NITROGEN-CONTAINING STABILIZER TOYOBO CO., LTD. (JA) 1977-03-22 US disclosed
US-3957905-A HALOGENATED BISPHENYL COMPOUND, ANTIMONY COMPOUND TOYO BOSEKI KABUSHIKI KAISHA (JA) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260081259-A1 METHOD FOR OPERATING A THERMAL MANAGEMENT ARRANGEMENT RAF1, PFKP, TP53RK ACHE 1335/4885CA2 850/4885CA1 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.